Antares Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.05.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, PSB, ATRS, VWTR (PR Newswire)
03.05.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CMPI, SBOW, SRRA, ATRS (PR Newswire)
28.04.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PLAN, WAVD, SRRA, ATRS (PR Newswire)
18.04.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates VWTR, ATRS, SBOW, SRRA (PR Newswire)
13.04.22	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SRRA, ATRS, OBNK (PR Newswire)
13.04.22	Pre-market Movers: ATRS, SRRA, NSTG, RPTX, CFLT… (RTTNews)
19.11.19	Healthcare Stocks That Hit New Highs (XBIT, DRNA, CRSP...) (RTTNews)
29.11.18	Antares Announces Commercial Availability Of XYOSTED Injection (RTTNews)
03.10.18	OGEN Spikes 200% In 2 Days, TRPX On A High, INO Turning Heads (RTTNews)
01.10.18	Antares Pharma Announces FDA Approval Of XYOSTED For Testosterone Replacement (RTTNews)
29.09.18	Week Ahead In Pharmaceuticals: 5 Stocks To Watch (OMER, BOLD, XLRN...) (RTTNews)
20.09.18	D-Day Nearing For Antares Pharma (RTTNews)
31.08.18	Biotech Stocks Facing FDA Decision In September (RTTNews)
14.08.18	XBIO To Report Phase 2 Data This Year, VNRX Abuzz, ATRS To Face FDA In Sep (RTTNews)
07.08.18	CRY Has Reason To Smile, AKCA Braces For Busy Year, GEMP Down After-hours (RTTNews)
06.08.18	Antares Pharma, Pfizer To Develop Drug Device Rescue Pen - Quick Facts (RTTNews)
13.03.18	Antares Pharma Posts Narrower Loss In Q4 - Quick Facts (RTTNews)
16.02.18	FDA To Decide On APRI's ED Drug, KURA Nails It, MBRX Dynamic, GLMD Awaits ARREST (RTTNews)
15.02.18	AMAG Gets FDA Nod, ABMD Hits All-time High, GLMD's NAFLD Trial Flops, NKTR Abuzz (RTTNews)
31.01.18	Double Blessing Or Double Whammy - What Awaits AMAG? (RTTNews)
26.01.18	Biotech Stocks Facing FDA Decision In February (RTTNews)
15.11.17	SHAREHOLDER ALERT: Pomerantz Law Reminds Shareholders with Losses on their Investment in Antares Pharma, Inc. of Class Action Lawsuit and Upcoming Deadline - ATRS (PR Newswire)
07.11.17	Antares Pharma Q3 Loss Narrows (RTTNews)
03.11.17	ANTARES LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Antares Pharma, Inc. To Contact The Firm (PR Newswire)
31.10.17	Scott+Scott, Attorneys at Law, LLP Alerts Investors to the Filing of a Securities Class Action Against Antares Pharma, Inc. (ATRS) (PR Newswire)
24.10.17	Lifshitz & Miller LLP Announces Investigation of Antares Pharma, Inc., CenturyLink, Inc., CytRx Corporation, Dentsply Sirona, Inc., Dr. Reddy's Laboratories Limited, J.Jill, Inc., and Navient... (PR Newswire)
24.10.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Antares Pharma, Inc. (ATRS) & Lead Plaintiff Deadline: December 22, 2017 (PR Newswire)
23.10.17	DBVT Disappoints, GSK Gets Greenlight, AIMT Catches Eyes, FDA Snubs ATRS (RTTNews)
18.10.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Antares Pharma, Inc. - ATRS (PR Newswire)
13.10.17	ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS (RTTNews)
29.09.17	Biotech Stocks Facing FDA Decision In October (RTTNews)
31.08.17	Medical Supplies Stock Performance Review -- Integra LifeSciences, Antares Pharma, Becton, Dickinson and Co., and Waters (PR Newswire)
08.08.17	Antares Pharma Q2 Net Loss Narrows, Revenues Rise - Quick Facts (RTTNews)
25.07.17	Today's Research Report Coverage on Medical Supplies Stocks -- Antares Pharma, Integra LifeSciences, Becton, Dickinson, and Waters (PR Newswire)
13.06.17	Stock Performance Review on Medical Supplies Industry -- Antares Pharma, Becton, Dickinson, Integra LifeSciences, and Waters (PR Newswire)
09.05.17	Antares Pharma Q1 Loss Narrows (RTTNews)
05.05.17	Research Reports Coverage on Medical Supplies Stocks -- Antares Pharma, Becton, Dickinson, Integra LifeSciences, and Waters (PR Newswire)
30.03.17	Technical Reports on Medical Supplies Stocks -- Endologix, Becton, Dickinson, Antares Pharma, and C. R. Bard (PR Newswire)
14.03.17	Antares Pharma Posts Narrower Loss In Q4 - Quick Facts (RTTNews)
28.02.17	LJPC Climbs 76%, VTVT On Track, Eventful October Awaits ACRX, ATRS (RTTNews)
14.02.17	Research Reports Coverage on Medical Supplies Stocks -- Endologix, Becton, Dickinson, Antares Pharma, and TransEnterix (PR Newswire)
31.01.17	Gainers & Losers Of The Day: CALA, EVOK, EYEG, OCRX, TENX... (RTTNews)
10.01.17	Technical Reports on Medical Supplies Stocks -- Endologix, Becton, Dickinson, Antares Pharma, and TransEnterix (PR Newswire)
21.11.16	How These Healthcare Stocks are Faring? -- Healthways, Antares Pharma, HEALTHSOUTH, and MEDNAX (PR Newswire)
07.05.15	ATRS Prices Offering At $2/Share (RTTNews)
25.02.15	Antares Announces Positive Pharmacokinetic Results From QuickShot Phase 3 Study (RTTNews)
18.11.14	Antares Pharma Appoints James Fickenscher As CFO - Quick Facts (RTTNews)
20.12.13	Antares Gets Notice Of Allowance For New Patent On Lyophilized Injectables (RTTNews)
08.10.13	Early Briefing and Review: Accuray Inc., Chelsea Therapeutics Intl. Ltd, ZIOPHARM Oncology Inc., and Antares Pharma Inc. (PR Newswire)
02.10.13	Dividend Increases, Research Nominations, New Treatment Options, and Clinical Trials - Research Report on Covidien, Ironwood, ICON, Novadaq, and Antares (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Antares Pharma IncShs

Aktien Top/Flop

Meistgelesene Nachrichten